Millennium Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.85M Buy
340,629
+142,424
+72% +$1.61M ﹤0.01% 2246
2025
Q1
$2.29M Buy
+198,205
New +$2.29M ﹤0.01% 2517
2024
Q2
Sell
-19,329
Closed -$229K 4236
2024
Q1
$229K Buy
+19,329
New +$229K ﹤0.01% 3621
2023
Q4
Hold
0
4313
2023
Q3
Sell
-27,935
Closed -$251K 4373
2023
Q2
$251K Sell
27,935
-52,768
-65% -$475K ﹤0.01% 3614
2023
Q1
$634K Sell
80,703
-395,548
-83% -$3.11M ﹤0.01% 3313
2022
Q4
$3.22M Sell
476,251
-1,707
-0.4% -$11.5K ﹤0.01% 2393
2022
Q3
$6.94M Buy
477,958
+377,641
+376% +$5.48M ﹤0.01% 1921
2022
Q2
$987K Buy
100,317
+83,169
+485% +$818K ﹤0.01% 3429
2022
Q1
$253K Buy
+17,148
New +$253K ﹤0.01% 4547
2021
Q4
Sell
-36,715
Closed -$641K 5424
2021
Q3
$641K Buy
+36,715
New +$641K ﹤0.01% 3994
2021
Q1
Sell
-28,797
Closed -$547K 4707
2020
Q4
$547K Sell
28,797
-33,981
-54% -$645K ﹤0.01% 3185
2020
Q3
$790 Buy
62,778
+15,316
+32% +$193 ﹤0.01% 2615
2020
Q2
$574K Buy
+47,462
New +$574K ﹤0.01% 2666
2020
Q1
Sell
-28,148
Closed -$501K 3420
2019
Q4
$501K Buy
28,148
+13,929
+98% +$248K ﹤0.01% 2748
2019
Q3
$164K Buy
14,219
+4,324
+44% +$49.9K ﹤0.01% 3194
2019
Q2
$219K Sell
9,895
-86,575
-90% -$1.92M ﹤0.01% 3168
2019
Q1
$2.76M Buy
+96,470
New +$2.76M ﹤0.01% 1854
2018
Q4
Sell
-52,041
Closed -$1.15M 3515
2018
Q3
$1.15M Buy
52,041
+38,924
+297% +$861K ﹤0.01% 2464
2018
Q2
$107K Sell
13,117
-216,131
-94% -$1.76M ﹤0.01% 3268
2018
Q1
$2.17M Sell
229,248
-7,336
-3% -$69.5K ﹤0.01% 2101
2017
Q4
$2.31M Buy
+236,584
New +$2.31M ﹤0.01% 2045
2016
Q3
Sell
-1,006
Closed -$9K 3150
2016
Q2
$9K Buy
+1,006
New +$9K ﹤0.01% 2880